Specifically, in only 14% (BRCA), 8% (LUAD), and 0% (SKCM) of the patients in the underpredicted group, neither mutations nor miRNA can provide an explanation for the low CD274 expression, which is 0–1% of the total patient population in all three cancer types (Fig. 5g–i). This evidence concerns the gene CD274 and cancer.